Skip to main content
. 2018 Jun 20;21(2):150–157. doi: 10.4048/jbc.2018.21.2.150

Figure 2. Subgroup analysis to estimate the benefits of cytokine-induced killer treatment. (A) N1,2,3 stages. (B) N0 stage. (C) I and IIA stages. (D) IIB and III stages. Left, disease-free survival (DFS) curves; right, overall survival (OS) curves.

Figure 2